Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2010-05-18 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2010
Regulatory Filings
2010-05-18 English
Director's Dealing 2010
Director's Dealing Classification · 99% confidence The document is titled 'MARKEDSMEDDELELSE' (Market Announcement) and specifically references '§ 28 A MEDDELELSE – INDBERETNING AF LEDENDE MEDARBEJDERES OG DISSES NÆRTSTÅENDES TRANSAKTIONER MED BLUE VISION A/S' AKTIER' (Notification pursuant to Section 28a - Reporting of transactions in the shares of Blue Vision A/S by management and closely associated persons). This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided definitions. The content details sales transactions by an entity controlled by a former board member. This maps precisely to the 'Director's Dealing' category (DIRS).
2010-05-14 English
Regulatory Filings 2010
Regulatory Filings
2010-05-14 Danish
AGM Information 2010
AGM Information Classification · 100% confidence The document is explicitly titled 'FORLØB AF ORIDNÆR GENERALFORSAMLING I BLUE VISION A/S' (Proceedings of the Annual General Meeting in Blue Vision A/S). It details the events that transpired during the meeting, including the chairman's report, approval of the annual report, election/re-election of the board and auditor, and significant resolutions passed, such as authorizing share buybacks and extensive amendments to the company's articles of association following new legislation. This content perfectly matches the description for AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2010-05-14 English
Regulatory Filings 2010
Regulatory Filings
2010-05-14 Danish
Director's Dealing 2010
Director's Dealing Classification · 99% confidence The document is titled 'MARKEDSMEDDELELSE' (Market Announcement) and specifically references '§ 28 A MEDDELELSE – INDBERETNING AF LEDENDE MEDARBEJDERES OG DISSES NÆRTSTÅENDES TRANSAKTIONER MED BLUE VISION A/S' AKTIER'. This directly translates to a notification regarding transactions in company shares by senior management and related parties, as required by securities law (§ 28a). This aligns perfectly with the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document details specific sales transactions, dates, and values.
2010-05-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.